- Home
- SWTX vs MLCO Comparison
SWTX vs MLCO Comparison
Compare SWTX & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- MLCO
- Stock Information
- Founded
- SWTX 2017
- MLCO 2004
- Country
- SWTX United States
- MLCO Hong Kong
- Employees
- SWTX N/A
- MLCO N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- MLCO Hotels/Resorts
- Sector
- SWTX Health Care
- MLCO Consumer Discretionary
- Exchange
- SWTX Nasdaq
- MLCO Nasdaq
- Market Cap
- SWTX 3.0B
- MLCO 2.4B
- IPO Year
- SWTX 2019
- MLCO 2006
- Fundamental
- Price
- SWTX $58.25
- MLCO $6.01
- Analyst Decision
- SWTX Strong Buy
- MLCO Buy
- Analyst Count
- SWTX 6
- MLCO 6
- Target Price
- SWTX $70.83
- MLCO $7.83
- AVG Volume (30 Days)
- SWTX 3.2M
- MLCO 4.3M
- Earning Date
- SWTX 02-20-2025
- MLCO 03-03-2025
- Dividend Yield
- SWTX N/A
- MLCO N/A
- EPS Growth
- SWTX N/A
- MLCO N/A
- EPS
- SWTX N/A
- MLCO N/A
- Revenue
- SWTX $191,589,000.00
- MLCO $4,540,808,000.00
- Revenue This Year
- SWTX $3,475.18
- MLCO $25.13
- Revenue Next Year
- SWTX $81.60
- MLCO $4.74
- P/E Ratio
- SWTX N/A
- MLCO N/A
- Revenue Growth
- SWTX 3417.33
- MLCO 50.42
- 52 Week Low
- SWTX $28.21
- MLCO $4.78
- 52 Week High
- SWTX $62.00
- MLCO $8.90
- Technical
- Relative Strength Index (RSI)
- SWTX 70.71
- MLCO 55.20
- Support Level
- SWTX $54.89
- MLCO $6.04
- Resistance Level
- SWTX $62.00
- MLCO $6.28
- Average True Range (ATR)
- SWTX 4.09
- MLCO 0.25
- MACD
- SWTX 1.35
- MLCO 0.08
- Stochastic Oscillator
- SWTX 85.90
- MLCO 71.67
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 82.5% from Macao with the rest largely from the Philippines as of first-half 2024.